ustekinumab [Ustekinumab]

tematický
120
Termíny

Stelara

 

CNTO 1275
CNTO-1275
Stelara

Perzistentní odkaz   https://www.medvik.cz/link/D000069549
Definice

A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.

DUI
D000069549 MeSH Prohlížeč
CUI
M0490173
RN
FU77B4U5Z0
Historická pozn.
2016 (2005)
Veřejná pozn.
2016; USTEKINUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2005-2011

D Chemikálie a léčiva
D12.776 proteiny 2 575
D12.776.124 krevní proteiny 909
D12.776.124.486 imunoproteiny 14
D12.776.124.486.485 imunoglobuliny 1 483
D12.776.124.486.485.114 protilátky 1 814
D12.776.124.486.485.114.224 monoklonální protilátky 4 611
D12.776.124.486.485.114.224.060 humanizované monoklonální protilátky 2 757
D12.776.124.486.485.114.224.060.125 abciximab 14
D12.776.124.486.485.114.224.060.250 adalimumab 346
D12.776.124.486.485.114.224.060.313 alemtuzumab 123
D12.776.124.486.485.114.224.060.344 basiliximab 2
D12.776.124.486.485.114.224.060.375 bevacizumab 444
D12.776.124.486.485.114.224.060.438 brentuximab vedotin 38
D12.776.124.486.485.114.224.060.500 certolizumab pegol 47
D12.776.124.486.485.114.224.060.750 cetuximab 185
D12.776.124.486.485.114.224.060.766 daklizumab 6
D12.776.124.486.485.114.224.060.782 denosumab 150
D12.776.124.486.485.114.224.060.790 gemtuzumab 16
D12.776.124.486.485.114.224.060.794 inotuzumab ozogamicin 11
D12.776.124.486.485.114.224.060.798 ipilimumab 251
D12.776.124.486.485.114.224.060.813 natalizumab 156
D12.776.124.486.485.114.224.060.829 nivolumab 425
D12.776.124.486.485.114.224.060.844 omalizumab 111
D12.776.124.486.485.114.224.060.860 palivizumab 12
D12.776.124.486.485.114.224.060.864 panitumumab 57
D12.776.124.486.485.114.224.060.866 ramucirumab 1
D12.776.124.486.485.114.224.060.868 ranibizumab 60
D12.776.124.486.485.114.224.060.875 trastuzumab 267
D12.776.124.486.485.114.224.060.937 ustekinumab 120
D12.776.124.790 sérové globuliny 61
D12.776.124.790.651 imunoglobuliny 1 483
D12.776.124.790.651.114 protilátky 1 814
D12.776.124.790.651.114.224 monoklonální protilátky 4 611
D12.776.124.790.651.114.224.060 humanizované monoklonální protilátky 2 757
D12.776.124.790.651.114.224.060.125 abciximab 14
D12.776.124.790.651.114.224.060.250 adalimumab 346
D12.776.124.790.651.114.224.060.375 alemtuzumab 123
D12.776.124.790.651.114.224.060.407 basiliximab 2
D12.776.124.790.651.114.224.060.438 bevacizumab 444
D12.776.124.790.651.114.224.060.469 brentuximab vedotin 38
D12.776.124.790.651.114.224.060.500 certolizumab pegol 47
D12.776.124.790.651.114.224.060.750 cetuximab 185
D12.776.124.790.651.114.224.060.766 daklizumab 6
D12.776.124.790.651.114.224.060.782 denosumab 150
D12.776.124.790.651.114.224.060.790 gemtuzumab 16
D12.776.124.790.651.114.224.060.794 inotuzumab ozogamicin 11
D12.776.124.790.651.114.224.060.798 ipilimumab 251
D12.776.124.790.651.114.224.060.813 natalizumab 156
D12.776.124.790.651.114.224.060.829 nivolumab 425
D12.776.124.790.651.114.224.060.844 omalizumab 111
D12.776.124.790.651.114.224.060.860 palivizumab 12
D12.776.124.790.651.114.224.060.864 panitumumab 57
D12.776.124.790.651.114.224.060.866 ramucirumab 1
D12.776.124.790.651.114.224.060.868 ranibizumab 60
D12.776.124.790.651.114.224.060.875 trastuzumab 267
D12.776.124.790.651.114.224.060.937 ustekinumab 120
D12.776.377 globuliny 68
D12.776.377.715 sérové globuliny 61
D12.776.377.715.548 imunoglobuliny 1 483
D12.776.377.715.548.114 protilátky 1 814
D12.776.377.715.548.114.224 monoklonální protilátky 4 611
D12.776.377.715.548.114.224.200 humanizované monoklonální protilátky 2 757
D12.776.377.715.548.114.224.200.125 abciximab 14
D12.776.377.715.548.114.224.200.250 adalimumab 346
D12.776.377.715.548.114.224.200.375 alemtuzumab 123
D12.776.377.715.548.114.224.200.407 basiliximab 2
D12.776.377.715.548.114.224.200.438 bevacizumab 444
D12.776.377.715.548.114.224.200.469 brentuximab vedotin 38
D12.776.377.715.548.114.224.200.500 certolizumab pegol 47
D12.776.377.715.548.114.224.200.750 cetuximab 185
D12.776.377.715.548.114.224.200.766 daklizumab 6
D12.776.377.715.548.114.224.200.782 denosumab 150
D12.776.377.715.548.114.224.200.790 gemtuzumab 16
D12.776.377.715.548.114.224.200.794 inotuzumab ozogamicin 11
D12.776.377.715.548.114.224.200.798 ipilimumab 251
D12.776.377.715.548.114.224.200.813 natalizumab 156
D12.776.377.715.548.114.224.200.829 nivolumab 425
D12.776.377.715.548.114.224.200.844 omalizumab 111
D12.776.377.715.548.114.224.200.860 palivizumab 12
D12.776.377.715.548.114.224.200.864 panitumumab 57
D12.776.377.715.548.114.224.200.866 ramucirumab 1
D12.776.377.715.548.114.224.200.868 ranibizumab 60
D12.776.377.715.548.114.224.200.875 trastuzumab 267
D12.776.377.715.548.114.224.200.937 ustekinumab 120